About 1 in 7 adult primary care patients visiting medical offices reported having used marijuana at least once in the past year.
The partnership will utilize Steep Hill's expertise in analytical testing to customize Eybna's production of terpene formulations for optimizing the medical benefits of cannabis.
Third party lab testing isn’t currently required by Health Canada, but the agency has already required ‘expanded’ testing for licensed producers to ensure that pesticide and additive requirements are being met.
Products containing either too little or too much CBD than labeled could negate potential clinical benefit to patients.
The agency has issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.
Preliminary studies indicate that cannabinoids can increase the potency and decrease the minimal required therapeutic dosages of antibacterial agents